Evaluation of rapid polymyxin NP test to detect colistin-resistant Klebsiella pneumoniae isolated in a tertiary Greek hospital

被引:21
|
作者
Malli, Ergina [1 ]
Florou, Zoi [1 ]
Tsilipounidaki, Katerina [1 ]
Voulgaridi, Ioanna [1 ]
Stefos, Aggelos [2 ]
Xitsas, Stelios [1 ]
Papagiannitsis, Costas C. [1 ]
Petinaki, Efthimia [1 ]
机构
[1] Univ Hosp Larissa, Dept Microbiol, Larisa, Greece
[2] Univ Hosp Larissa, Dept Internal Med, Larisa, Greece
关键词
Enterobacteriaceae; Carbapenemases; Broth-microdilution method; VITEK (R) 2; BD Phoenix (TM); CARBAPENEM-RESISTANT; AGAR DILUTION; MGRB GENE; VITEK; ENTEROBACTERIACEAE; SUSCEPTIBILITY; ETEST; INACTIVATION; MICROSCAN; EMERGENCE;
D O I
10.1016/j.mimet.2018.08.010
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The efficiency of Rapid Polymyxin NP test for detection of colistin-resistant isolates was tested against a collection of 131 non-repetitive Klebsiella pneumoniae, including 98 colistin-resistant and 33 colistin-susceptible isolates. In addition, the performance of this test was compared with those of the automated systems, BD Phoenix (TM) and VITEK (R) 2, and the Etest. Determination of imipenem and meropenem MICs showed that 95 of colistin-resistant (Col-R) isolates were also resistant to at least one carbapenem. Characterization of colistin resistance mechanisms showed that 75 out of 98 Col-R isolates were associated with the presence of alterations in the mgrB gene, while no mcr genes were detected among our isolates. Rapid Polymyxin NP correctly detected 97 out of 98 colistin-resistant isolates (Geometric mean MIC value 9.89 mg/L), except one ST147 K. pneumoniae harboring a wild-type mgrB gene (MIC: 8 mg/L), yielding a sensitivity 99%. The other methods gave more false negative results with colistin-resistant strains; BD Phoenix (TM),VITEK (R) 2, and the gradient Etest missed five, two and three colistin-resistant, respectively (95%, 98% and 97%). The Rapid Polymyxin NP test gave false positive results with six isolates, for which colistin MICs were 1-2 mg/L (specificity 82%). Despite the fact that Rapid Polymyxin exhibited lower specificity than other methods (82% versus 94%, 88% and 85%), it is easy-to-perform and rapid. Thus, these findings indicate that the Rapid Polymyxin NP test can be an initial tool for the detection of colistin-resistant isolates.
引用
收藏
页码:35 / 39
页数:5
相关论文
共 50 条
  • [41] Genome analysis of an OXA-48-producing carbapenem- and colistin-resistant Klebsiella pneumoniae sequence type 11 clone isolated from an inpatient
    Bolourchi, Negin
    Shahcheraghi, Fereshteh
    Giske, Christian G.
    Nematzadeh, Shoeib
    Solgi, Hamid
    Badmasti, Farzad
    GENE REPORTS, 2021, 25
  • [42] Molecular Characterization of Carbapenem-Resistant Klebsiella pneumoniae Species Isolated From a Tertiary Hospital, Ankara, Turkey
    Celikbilek, Nevreste
    Unaldi, Ozlem
    Kirca, Fisun
    Gozalan, Aysegul
    Acikgoz, Ziya C.
    Durmaz, Riza
    JUNDISHAPUR JOURNAL OF MICROBIOLOGY, 2017, 10 (10)
  • [43] Emergence and dissemination of colistin-resistant Klebsiella pneumoniae isolates expressing OXA-48 plus CTX-M-15 in patients not previously treated with colistin in a Spanish university hospital
    Barragan-Prada, Hugo
    Ruiz-Hueso, Paula
    Tedim, Ana P.
    Gonzalez-Candelas, Fernando
    Carlos Galan, Juan
    Canton, Rafael
    Morosini, Maria-Isabel
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2019, 93 (02) : 147 - 153
  • [44] Extensive outbreak of colistin resistant, carbapenemase (blaOXA-48, blaNDM) producing Klebsiella pneumoniae in a large tertiary care hospital, India
    Swati Sharma
    Tuhina Banerjee
    Ashok Kumar
    Ghanshyam Yadav
    Sriparna Basu
    Antimicrobial Resistance & Infection Control, 11
  • [45] Extensive outbreak of colistin resistant, carbapenemase (blaOXA-48, blaNDM) producing Klebsiella pneumoniae in a large tertiary care hospital, India
    Sharma, Swati
    Banerjee, Tuhina
    Kumar, Ashok
    Yadav, Ghanshyam
    Basu, Sriparna
    ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL, 2022, 11 (01)
  • [46] Identification of NDM-1 producing and colistin resistant Klebsiella pneumoniae ST11: A highly drug-resistant strain detected in intensive care unit of a Greek tertiary care hospital
    Chatzidimitriou, Maria
    Tsolakidou, Pandora
    Kyriazidi, Maria Anna
    Chatzopoulou, Fani
    Varlamis, Sotiris
    Mavridou, Maria
    Kalinderi, Kallirhoe
    Kyriazidis, Kyriazis Athanasios
    Mitka, Stella
    ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA, 2025,
  • [47] Risk Factors and Molecular Mechanism of Polymyxin B Resistance in Carbapenem-Resistant Klebsiella pneumoniae Isolates from a Tertiary Hospital in Fujian, China
    Xu, Xiaohong
    Zhu, Rongping
    Lian, Siyan
    Zhang, Hui
    Chen, Xin
    Fan, Lingfang
    Chen, Peisong
    Cao, Yingping
    INFECTION AND DRUG RESISTANCE, 2022, 15 : 7485 - 7494
  • [48] Molecular Characterization and Risk Factors of Carbapenem-Resistant Hypervirulent Klebsiella pneumoniae Isolated from Chinese Tertiary Hospital
    Zhu, Rongping
    Li, Ju
    Lian, Siyan
    Li, Yishan
    Cai, Meili
    Cao, Yingping
    Xu, Xiaohong
    INFECTION AND DRUG RESISTANCE, 2025, 18 : 83 - 92
  • [49] Detection of the emergence of mcr-1-mediated colistin-resistant Escherichia coli and Klebsiella pneumoniae through a hospital-based surveillance in an oncology center in eastern India
    Roy, Samadrita
    Das, Parijat
    Das, Surojit
    Roy, Subhanita
    Pal, Soumik
    Joy, Vinitha Mary
    Mukherjee, Sudipta
    Bhattacharyya, Arpita
    Goel, Gaurav
    Bhattacharya, Sanjay
    Mathur, Purva
    Walia, Kamini
    Chandy, Mammen
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2020, 41 (03): : 378 - 380
  • [50] Colistin- and carbapenem-resistant Klebsiella pneumoniae carrying mcr-1 and blaOXA-48 isolated at a paediatric hospital in Vietnam
    Berglund, Bjorn
    Ngoc Thi Bich Hoang
    Tarnberg, Maria
    Ngai Kien Le
    Welander, Jenny
    Nilsson, Maud
    Dung Thi Khanh Khu
    Nilsson, Lennart E.
    Olson, Linus
    Hai Thanh Le
    Larsson, Mattias
    Hanberger, Hakan
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2018, 73 (04) : 1100 - 1102